Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

EssilorLuxottica Establishes a Scientific Advisory Committee

EssilorLuxottica has announced the creation of a Scientific Advisory Committee to boost its innovation, according to a company press release.


EssilorLuxottica Establishes a Scientific Advisory Committee

Formation of the Committee

According to the press release, EssilorLuxottica has formed a Scientific Advisory Committee consisting of scientists and thought leaders in the fields of science, technology, and health. The purpose of this committee is to provide strategic advice and insights on future opportunities, thereby aiding the company in advancing its research priorities, including ophthalmology, oculomics, physics, optics, audiology, artificial intelligence, and ethics.

Distinguished Experts on the Committee

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The committee includes five renowned experts. Among them are Prof. Alain Aspect, winner of the 2022 Nobel Prize in Physics, and Prof. Alessio Figalli, recipient of the 2018 Fields Medal. The committee also includes Prof. Sharon Kujawa, awarded the 2017 Callier Prize, Prof. José-Alain Sahel, winner of the 2024 Wolf Prize, and Prof. Effy Vayena, an expert in bioethics. These professionals are recognized for their significant contributions to their respective fields.

Leadership's Vision for Innovation

Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO of EssilorLuxottica, expressed in the press release their ambition to advance fields such as ophthalmology, audiology, and other life sciences through this new collaboration. They emphasize that the committee is a significant step in the company’s innovation strategy, aiming to transform scientific discoveries into tangible benefits for patients.



Sector Luxe Fournitures Médicales


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 28 491 millions d'euros
  • Revenue growth: 11,2 %
  • EBITDA: 6 492 millions d'euros
  • EBITDA margin: 22,8 %
  • Net income: 2 443 millions d'euros
  • Free cash flow: 2 796 millions d'euros
  • Net debt: 10 853 millions d'euros
  • Dividend per share: 4,00 euros
Guidance from the release
  • C’est une année historique pour EssilorLuxottica : pour la première fois depuis l’origine du Groupe, notre chiffre d’affaires a enregistré une croissance à deux chiffres à taux de change constant, après un quatrième trimestre affichant une croissance record de 18,4 %.
  • Résultats annuels 2025 marquent une croissance du chiffre d’affaires de 11,2% et une marge opérationnelle ajustée de 15,7%; le cash-flow libre atteint 2,8 milliards d'euros; dividende proposé de 4,00 euros; acquisitions et initiatives med-tech renforcent le positionnement.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit